GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Other Financing

GemVax & KAEL Co (XKRX:082270) Other Financing : ₩75 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Other Financing?

GemVax & KAEL Co's Other Financing for the three months ended in Sep. 2024 was ₩0 Mil.

GemVax & KAEL Co's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was ₩75 Mil.

GemVax & KAEL Co Other Financing Historical Data

The historical data trend for GemVax & KAEL Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Other Financing Chart

GemVax & KAEL Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GemVax & KAEL Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 75.00 -

GemVax & KAEL Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GemVax & KAEL Co Other Financing Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

GemVax & KAEL Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Other Financing
Comparable Companies
XKRX:348210 XKRX:272290 XKRX:319660 XKRX:031980 XKRX:183300 XKRX:074600 XKRX:039440 XKRX:131290 XKRX:281820 XKRX:053610 XAMS:ASML AMAT LRCX KLAC TSE:8035 SHSE:601012 XAMS:ASM TSE:6146 TSE:6857 SZSE:002371
Traded in Other Exchanges
N/A
Address
894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510
Website
http://www.kael.co.kr
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines